Company logo

ARCT - Arcturus Therapeutics Holdings Inc.

NASDAQ -> Healthcare -> Biotechnology
San Diego, United States
Type: Equity

ARCT price evolution
ARCT
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $347 $346.92 $378.47 $327.94
Short term investments
Net receivables $32.06 $38.22 $2.8 $92.48
Inventory
Total current assets $386.59 $393.27 $385.24 $424.56
Long term investments $1.89 $22.13 $2.13 $2.12
Property, plant & equipment $40.93 $42.25 $43.27 $44.19
Goodwill & intangible assets
Total noncurrent assets $42.81 $64.38 $45.4 $46.31
Total investments $1.89 $22.13 $2.13 $2.12
Total assets $429.4 $457.65 $430.65 $470.86
Current liabilities
Accounts payable $5.28 $18.36 $13.62 $19.34
Deferred revenue $87.33 $82.68 $73.69 $59.06
Short long term debt
Total current liabilities $81.99 $87.68 $90.34 $90.13
Long term debt $25.91 $47.02 $28.11 $29.19
Total noncurrent liabilities $68.9 $89.91 $55.13 $51.48
Total debt $25.91 $47.02 $28.11 $29.19
Total liabilities $150.89 $177.59 $145.47 $141.62
Shareholders' equity
Retained earnings -$367.87 -$356.16 -$339.94 -$287.39
Other shareholder equity
Total shareholder equity $278.51 $280.06 $285.18 $329.25
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $347 $391.88 $370.49 $462.89
Short term investments
Net receivables $32.06 $2.76 $3.37 $2.13
Inventory
Total current assets $386.59 $403.33 $378.96 $467.79
Long term investments $1.89 $2.09 $2.59 $0.11
Property, plant & equipment $40.93 $44.96 $11.26 $8.56
Goodwill & intangible assets
Total noncurrent assets $42.81 $47.05 $13.85 $8.67
Total investments $1.89 $2.09 $2.59 $0.11
Total assets $429.4 $450.39 $392.81 $476.46
Current liabilities
Accounts payable $5.28 $7.45 $10.06 $10.77
Deferred revenue $87.33 $48.72 $63.41 $30.62
Short long term debt $60.66 $22.47
Total current liabilities $81.99 $126.98 $99.54 $49.52
Long term debt $25.91 $30.22 $45.13 $17.87
Total noncurrent liabilities $68.9 $53.09 $65.07 $30.38
Total debt $25.91 $90.87 $67.61 $17.87
Total liabilities $150.89 $180.07 $164.6 $79.9
Shareholders' equity
Retained earnings -$367.87 -$338.14 -$347.49 -$143.82
Other shareholder equity
Total shareholder equity $278.51 $270.31 $228.21 $396.55
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $30.86 $45.14 $10.52 $80.28
Cost of revenue
Gross Profit $30.86 $45.14 $10.52 $80.28
Operating activities
Research & development $36.62 $51.08 $52.67 $51.77
Selling, general & administrative $12.51 $13.38 $13.22 $13.76
Total operating expenses $49.13 $64.45 $65.89 $65.53
Operating income -$18.27 -$19.31 -$55.37 $14.76
Income from continuing operations
EBIT -$18.33 -$19.31 -$55.23 $48.38
Income tax expense $0.26 $0.89 $0.58 $0.1
Interest expense -$6.88 -$3.98 -$3.25 -$2.48
Net income
Net income -$11.71 -$16.22 -$52.55 $50.75
Income (for common shares) -$11.71 -$16.22 -$52.55 $50.75
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $166.8 $206 $12.36 $9.54
Cost of revenue
Gross Profit $166.8 $206 $12.36 $9.54
Operating activities
Research & development $192.13 $147.75 $173.76 $57.85
Selling, general & administrative $52.87 $46.07 $41.45 $23.22
Total operating expenses $245 $193.82 $215.21 $81.06
Operating income -$78.2 $12.18 -$202.85 -$71.52
Income from continuing operations
EBIT -$44.48 $11.06 -$201.75 -$71.79
Income tax expense $1.83 $1.29
Interest expense -$16.59 $0.42 $1.92 $0.36
Net income
Net income -$29.73 $9.35 -$203.67 -$72.15
Income (for common shares) -$29.73 $9.35 -$203.67 -$72.15
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$11.71 -$16.22 -$52.55 $50.75
Operating activities
Depreciation $0.81 $0.83 $0.74 $0.58
Business acquisitions & disposals
Stock-based compensation $8.81 $9.27 $8.38 $8.18
Total cash flows from operations -$0.63 -$32.41 $50.81 -$35.87
Investing activities
Capital expenditures -$0.88 -$0.98 -$0.35 -$0.69
Investments
Total cash flows from investing -$0.88 -$0.98 -$0.35 -$0.69
Financing activities
Dividends paid
Sale and purchase of stock $1.34 $1.84 $0.09
Net borrowings -$20 $20 -$27.36
Total cash flows from financing -$18.66 $21.84 $0.09 -$27.36
Effect of exchange rate
Change in cash and equivalents -$20.16 -$11.55 $50.55 -$63.93
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$29.73 $9.35 -$203.67 -$72.15
Operating activities
Depreciation $2.96 $1.53 $1.19 $0.88
Business acquisitions & disposals
Stock-based compensation $34.65 $30.61 $28.91 $6.76
Total cash flows from operations -$18.1 $31.99 -$135.04 -$42.86
Investing activities
Capital expenditures -$2.9 -$7.73 -$3.41 -$1.74
Investments
Total cash flows from investing -$2.9 -$7.73 -$3.41 -$1.74
Financing activities
Dividends paid
Sale and purchase of stock $3.28 $2.14 $1.42 $436.14
Net borrowings -$27.36 -$5 $46.6
Total cash flows from financing -$24.09 -$2.86 $48.02 $436.14
Effect of exchange rate
Change in cash and equivalents -$45.09 $21.41 -$90.43 $391.54
Fundamentals
Market cap $905.98M
Enterprise value $584.88M
Shares outstanding 26.83M
Revenue $166.80M
EBITDA -$41.52M
EBIT -$44.48M
Net Income -$29.73M
Revenue Q/Q -80.75%
Revenue Y/Y -19.03%
P/E ratio -30.48
EV/Sales 3.51
EV/EBITDA -14.09
EV/EBIT -13.15
P/S ratio 5.43
P/B ratio 3.25
Book/Share 10.38
Cash/Share 12.93
EPS -$1.11
ROA -6.65%
ROE -10.14%
Debt/Equity 0.54
Net debt/EBITDA 4.72
Current ratio 4.72
Quick ratio 4.72